Evidence map›Paper›PMID 30866434›Full record

ArticleInternational journal of molecular sciences2019

Zijian Pan, Eric K Dumas, Christina Lawrence, Lance Pate, Sherri Longobardi, Xiaodong Wang, Judith A James, Susan Kovats, A Darise Farris

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Neutrophil death-more than meets the eye.Experimental hematology · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Dying to Defend: Neutrophil Death Pathways and their Implications in Immunity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zijian PanArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA. zijian-pan@omrf.org.
Eric K DumasArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA. eric_dumas@hms.harvard.edu.
Christina LawrenceArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA. christina-lawrence@omrf.org.
Lance PateArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA. lcpate86@att.net.
Sherri LongobardiArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA. sherri-longobardi@omrf.org.
Xiaodong WangCenter for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. xiaodonw@unc.edu.
Judith A JamesArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA. judith-james@omrf.org.ORCID 0000-0002-9574-7355
Susan KovatsArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA. susan-kovats@omrf.org.ORCID 0000-0001-5479-9952
A Darise FarrisArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA. darise-farris@omrf.org.
Oklahoma Medical Research Foundation · USUniversity of North Carolina at Chapel Hill · US

Funding

Translation of immunologic technologies from basic research into pre-clinical nonU19AI062629 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI COGGESHALL, KENNETH MARK · 2004 to 2023
$56.2M
National Cancer Institute HHSN261200800001ENational Institute of Allergy and Infectious Diseases AI062629NIAID NIH HHS U19 AI062629
6 · The paper itself

Abstract

The

Indexed as

Antigens, BacterialAntigens, SurfaceBacillus anthracisBacterial ToxinsCell PolarityCells, Culturedc-Mer Tyrosine KinaseCoculture TechniquesCyclic AMPDexamethasoneDose-Response Relationship, DrugHumansInterleukin-10Interleukin-4MacrophagesMilk Proteinsanthrax toxinAntigens, BacterialAntigens, SurfaceBacterial Toxinsc-Mer Tyrosine KinaseCyclic AMPDexamethasoneIL10 protein, humanIL4 protein, humanintegrin alphaVbeta5Interleukin-10Interleukin-4MERTK protein, humanMFGE8 protein, humanMilk ProteinsProtein SReceptors, VitronectinBacillus anthracisEdema Toxinefferocytosismacrophage

Identifiers

PMID30866434
PMCPMC6429438
OpenAlexW2919698276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.